North America holds a substantial share of the Cancer Tissue Diagnostics Market, driven by its robust healthcare infrastructure, extensive cancer research activities, and growing emphasis on precision oncology. The region benefits from widespread adoption of advanced diagnostic technologies, including molecular pathology, immunohistochemistry, digital pathology, and genomic testing solutions....